Статья

Polymer Particles Bearing Recombinant LEL CD81 as Trapping Systems for Hepatitis C Virus

D. Polyakov, E. Sinitsyna, N. Grudinina, M. Antipchik, R. Sakhabeev, V. Korzhikov-Vlakh, M. Shavlovsky, E. Korzhikova-Vlakh, T. Tennikova,
2021

Hepatitis C is one of the most common social diseases in the world. The improvements in both the early diagnostics of the hepatitis C and the treatment of acute viremia caused by hepatitis C virus are undoubtedly an urgent task. In present work, we offered the micro- and nanotraps for the capturing of HCV. As a capturing moiety, we designed and synthesized in E. coli a fusion protein consisting of large extracellular loop of CD81 receptor and streptavidin as spacing part. The obtained protein has been immobilized on the surface of PLA-based micro- and nanoparticles. The developed trapping systems were characterized in terms of their physico-chemical properties. In order to illustrate the ability of developed micro- and nanotraps to bind HCV, E2 core protein of HCV was synthesized as a fusion protein with GFP. Interaction of E2 protein and hepatitis C virus-mimicking particles with the developed trapping systems were testified by several methods.

Цитирование

Похожие публикации

Версии

  • 1. Version of Record от 2021-05-07

Метаданные

Об авторах
  • D. Polyakov
    Institute of Experimental Medicine, Acad. Pavlov Street 12, 197376 St. Petersburg, Russia;, ravendoctor@mail.ru, (D.P.);, strangecatnap@gmail.com, (N.G.);, helm505@mail.ru, (R.S.);, mmsch@rambler.ru, (M.S.)
  • E. Sinitsyna
    Institute of Macromolecular Compounds, Russian Academy of Sciences, Bolshoy pr. 31, 199004 St. Petersburg, Russia;, kat_sinitsyna@mail.ru, (E.S.);, volokitinamariya@yandex.ru, (M.A.), Institute of Chemistry, Saint-Petersburg State University, Universitetsky pr. 26, 198504 St. Petersburg, Russia;, v.korzhikov-vlakh@spbu.ru
  • N. Grudinina
    Institute of Experimental Medicine, Acad. Pavlov Street 12, 197376 St. Petersburg, Russia;, ravendoctor@mail.ru, (D.P.);, strangecatnap@gmail.com, (N.G.);, helm505@mail.ru, (R.S.);, mmsch@rambler.ru, (M.S.)
  • M. Antipchik
    Institute of Macromolecular Compounds, Russian Academy of Sciences, Bolshoy pr. 31, 199004 St. Petersburg, Russia;, kat_sinitsyna@mail.ru, (E.S.);, volokitinamariya@yandex.ru, (M.A.)
  • R. Sakhabeev
    Institute of Experimental Medicine, Acad. Pavlov Street 12, 197376 St. Petersburg, Russia;, ravendoctor@mail.ru, (D.P.);, strangecatnap@gmail.com, (N.G.);, helm505@mail.ru, (R.S.);, mmsch@rambler.ru, (M.S.)
  • V. Korzhikov-Vlakh
    Institute of Chemistry, Saint-Petersburg State University, Universitetsky pr. 26, 198504 St. Petersburg, Russia;, v.korzhikov-vlakh@spbu.ru
  • M. Shavlovsky
    Institute of Experimental Medicine, Acad. Pavlov Street 12, 197376 St. Petersburg, Russia;, ravendoctor@mail.ru, (D.P.);, strangecatnap@gmail.com, (N.G.);, helm505@mail.ru, (R.S.);, mmsch@rambler.ru, (M.S.)
  • E. Korzhikova-Vlakh
    Institute of Macromolecular Compounds, Russian Academy of Sciences, Bolshoy pr. 31, 199004 St. Petersburg, Russia;, kat_sinitsyna@mail.ru, (E.S.);, volokitinamariya@yandex.ru, (M.A.), Institute of Chemistry, Saint-Petersburg State University, Universitetsky pr. 26, 198504 St. Petersburg, Russia;, v.korzhikov-vlakh@spbu.ru
  • T. Tennikova
    Institute of Chemistry, Saint-Petersburg State University, Universitetsky pr. 26, 198504 St. Petersburg, Russia;, v.korzhikov-vlakh@spbu.ru
Название журнала
  • Pharmaceutics
Том
  • 13
Выпуск
  • 5
Страницы
  • 672
Издатель
  • MDPI
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY
Правовой статус документа
  • Свободная лицензия
Источник
  • dimensions